Atlas Trials

A Research Study Looking at Similarity Between Once-weekly Semaglutide Versions for Different Injection Pens

Clinical trial NCT04152915 · COMPLETED

Trial details

NCT number
NCT04152915
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy VolunteersDiabetes Mellitus, Type 2
Start date
2019-11-25
Primary completion
2020-05-25
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.